SCHEMBL4615376

SCHEMBL4615376

O=C(O)[C@@H]1C[C@@H](Oc2ncnc3ccc(Br)cc23)CN1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.48
ALDH1A1 P00352 3/20 0.40
PIK3CD O00329 8/20 0.39
PIK3CA P42336 7/20 0.39
PIK3CB P42338 7/20 0.39
PIK3CG P48736 7/20 0.39
USP2 O75604 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RXFP1 Q9HBX9 2/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 1/20 0.36
PDGFRB P09619 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1244173 0.86 IRAK4 (0.48) IRAK4ALDH1A1PIK3CDPIK3CAPIK3CB
SCHEMBL2744222 0.83 PLG (0.37) IRAK4
SCHEMBL3502900 0.79 RXFP1 (0.35) ALDH1A1RXFP1KMT2AKDM4E
SCHEMBL8246884 0.79 PIK3CD (0.49) IRAK4ALDH1A1PIK3CDPIK3CAPIK3CB
SCHEMBL4531833 0.76 RXFP1 (0.46) ALDH1A1USP2RXFP1KMT2A
Hydrochloric Acid SCHEMBL4603256 0.75 IRAK4 (0.47) IRAK4ALDH1A1USP2CYP1A2CYP3A4
SCHEMBL25342628 0.75 HCRTR1 (0.46) ALDH1A1SMN1; SMN2KDM4E
SCHEMBL3501306 0.74 KDR (0.32)
SCHEMBL3503157 0.74 KDR (0.31)
SCHEMBL28842110 0.74 POLB (0.40) KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1913016-B1 MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2013-01-16 EP disclosed
US-8278322-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2012-10-02 US disclosed
EP-1913016-A1 MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS Merck & Co., Inc. (US) 2008-04-23 EP disclosed
WO-2007016441-A1 MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS MERCK & CO., INC. (US) 2007-02-08 WO disclosed